AbbVie Valuation Overview

ABBV -- USA Stock  

USD 93.78  0.36  0.39%

AbbVie shows prevailing Real Value of $84.0555 per share. The current price of the firm is $93.78. At this time the firm appears to be over valued. Macroaxis approximates value of AbbVie from analyzing the firm fundamentals such as Profit Margin of 20.84% and Return On Equity of 489.67% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Valuation Drivers Correlation
Click cells to compare fundamentals   View All Correlations
AbbVie Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    
AbbVie Market Cap
AbbVie is rated fifth in market capitalization category among related companies. Market capitalization of Drug Manufacturers - Major industry is presently estimated at about 1.57 Trillion. AbbVie holds roughly 139.71 Billion in market capitalization claiming about 9% of equities under Drug Manufacturers - Major industry.
Capitalization  Workforce  Valuation  Revenue  Total debt
Horizon     30 Days    Login   to change
AbbVie is rated below average in five year return category among related companies. It is number one stock in last dividend paid category among related companies creating about  1.21  of Last Dividend Paid per Five Year Return.

Current Market Valuation

AbbVie Valuation Boundaries

Over Valued
September 26, 2018
93.78
Market Value
84.06
Real Value
Target Odds
  
103.16
Upside
AbbVie is not too risky asset. Calculation of real value of AbbVie is based on 1 month time horizon. Increasing AbbVie time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

AbbVie Enterprise Value Fundamentals

Quick Ratio0.55
Earnings Quarterly Growth3.60%
Revenue Growth19.20%
Payout Ratio73.02%
Enterprise Value To Ebitda13.81
Earnings Growth5.70%
Enterprise Value To Revenue5.78
Check also Trending Equities. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Search macroaxis.com